U

Ultimovacs ASA
OSE:ULTI

Watchlist Manager
Ultimovacs ASA
OSE:ULTI
Watchlist
Price: 14.5 NOK 0.69%
Market Cap: 293.3m NOK

Operating Margin
Ultimovacs ASA

0%
Current
0%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-151.3m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Ultimovacs ASA
Glance View

Market Cap
293.3m NOK
Industry
Biotechnology

Ultimovacs AS operates as a pharmaceutical company. The company is headquartered in Oslo, Oslo. The company went IPO on 2019-06-03. The firm's lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase. UV1 is being developed as a therapeutic cancer vaccine which may serve as a platform for use in combination with other immuno-oncology drugs which require an ongoing T cell response for their mode of action. The firm is performing a broad clinical development program with clinical trials in Europe and the USA.

ULTI Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-151.3m
/
Revenue
0
What is the Operating Margin of Ultimovacs ASA?

Based on Ultimovacs ASA's most recent financial statements, the company has Operating Margin of 0%.

Back to Top